✦ LIBER ✦

411 A phase I trial of the histone deacetylase inhibitor panobinostat (LBH589) and epirubicin in patients with solid tumor malignancies

✍ Scribed by A.P. Moore; S. Thomas; C.J. Ryan; T.M. Jahan; S.G. DuBois; J.K. Chan; K.T. Thurn; A. Reinhert; A. Daud; P.N. Munster

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of oral panobinostat (LB

✍ Akira Fukutomi, Kiyohiko Hatake, Kaoru Matsui, Sakura Sakajiri, Tomonori Hirashi 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 223 KB

Phase II study of the histone deacetylas

✍ Sophie Dimicoli; Elias Jabbour; Gautam Borthakur; Tapan Kadia; Zeev Estrov; Hui 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 850 KB

A Phase I/II Trial Evaluating the Use of

✍ Perez, Lia Elena; Fernandez, Hugo; Tomblyn, Marcie; Locke, Frederick; Field, Ter 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

A Phase II Trial of Panobinostat, a Hist

✍ Hainsworth, John D.; Infante, Jeffrey R.; Spigel, David R.; Arrowsmith, Edward R 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 194 KB

344 A Phase I Study of Histone Deacetyla

✍ Zorzi, A.P.; Bernstein, M.; Samson, Y.; Wall, D.A.; Desai, S.; Wainman, N.; Eise 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

393 POSTER First-in-man Phase I trial of

✍ J.E. Ang; B. Hauns; A. Mais; A. Parker; R. Lal; D. Olmos; M. Mollenhauer; A. Wal 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 76 KB